6 results on '"Zhang, Meng‐Xia"'
Search Results
2. Efficacy of local therapy to metastatic foci in nasopharyngeal carcinoma: large-cohort strictly-matched retrospective study.
- Author
-
Zhang, Meng-Xia, Liu, Ting, You, Rui, Zou, Xiong, Liu, Yong-Long, Ding, Xi, Duan, Chong-Yang, Xu, Han-Shi, Liu, You-Ping, Jiang, Rou, Wang, Zhi-Qiang, Lin, Chao, Xie, Yu-Long, Chen, Si-Yuan, Ouyang, Yan-Feng, Xie, Ruo-Qi, Hua, Yi-Jun, Sun, Rui, Huang, Pei-Yu, and Wang, Shun-Lan
- Abstract
Background: Studies of local therapy (LT) to metastatic foci from nasopharyngeal carcinoma (NPC) are inconsistent and controversial. Here, we aimed to explore the survival benefit of LT directed at metastatic foci from NPC. Methods: A retrospective analysis was conducted in NPC patients with liver, lung, and/or bone metastases. The postmetastatic overall survival (OS) rate was analyzed using the Kaplan–Meier method and compared by the log-rank test. Multivariate analysis was performed using the Cox hazard model. Subgroup analyses evaluating the effect of LT were performed for prespecified covariates. Propensity score matching was applied to homogenize the compared arms. Results: Overall, 2041 of 2962 patients were eligible for analysis. At a median follow-up of 43.4 months, the 5-year OS improved by an absolute difference of 14.6%, from 46.2% in the LT group versus 31.6% in the non-LT group, which led to a hazard ratio of 0.634 for death (p < 0.001). Matched-pair analyses confirmed that LT was associated with improved OS (p = 0.003), and the survival benefits of LT remained consistent in the subcohorts of liver and lung metastasis (p = 0.009 and p = 0.007, respectively) but not of bone metastasis (BoM; p = 0.614). Radiotherapy was predominantly used for BoM and biological effective dose (BED) >60 Gy was found to yield more survival benefit than that of BED ⩽ 60 Gy. Conclusions: The addition of LT directed at metastasis has demonstrated an improvement to OS compared with non-LT group in the present matched-pair study, especially for patients with liver and/or lung metastases. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
3. Transcervical endoscopic retropharyngeal lymph node (RPLN) dissection in nasopharyngeal carcinoma with RPLN recurrence.
- Author
-
Liu, You‐Ping, Wang, Shun‐Lan, Zou, Xiong, You, Rui, Yang, Qi, Zhang, Meng‐Xia, Wang, Zhi‐Qiang, Lin, Mei, Xie, Yu‐Long, Chen, Si‐Yuan, Ouyang, Yan‐Feng, Yu, Zi‐Kun, Liu, Xue‐Kui, Sun, Rui, Hua, Yi‐Jun, Huang, Pei‐Yu, Li, Hao, and Chen, Ming‐Yuan
- Subjects
NASOPHARYNX cancer ,LYMPH nodes ,INJURY complications ,SURVIVAL analysis (Biometry) ,PROGRESSION-free survival - Abstract
Background: Surgical access for retropharyngeal lymph node (RPLN) dissection is difficult. We aimed to examine the efficacy of transcervical endoscopic RPLN dissection (TSE‐RPLND) for recurrent RPLN in nasopharyngeal carcinoma (NPC). Methods: From April 2013 to February 2019, a total of 31 patients with NPC diagnosed with RPLN recurrence underwent TSE‐RPLND. The clinical characteristics, complications, and survival outcomes were retrospectively analyzed. Results: The mean duration of surgery, quantity of bleeding and postoperative hospitalization stay were 347.9 minutes, 107.7 mL, and 8.7 days, respectively. After a median follow‐up of 31.0 months, the 2‐year locoregional relapse‐free survival, distant metastasis‐free survival, progression‐free survival, and overall survival rates were 63.9%, 95.2%, 59.9%, and 83.3%, respectively. The long‐term incidences of swallowing problems, permanent nutrient tube, tongue atrophy, and shoulder problems were 6 (19.4%), 3 (9.7%), 3 (9.7%), and 3 (9.7%), respectively. Conclusions: TSE‐RPLND is an effective method to treat RPLN recurrence in NPC, but nerve injury‐related complications should not be ignored. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
4. Intensity-modulated radiotherapy prolongs the survival of patients with nasopharyngeal carcinoma compared with conventional two-dimensional radiotherapy: A 10-year experience with a large cohort and long follow-up.
- Author
-
Zhang, Meng-Xia, Li, Jing, Shen, Guo-Ping, Zou, Xiong, Xu, Jun-Jie, Jiang, Rou, You, Rui, Hua, Yi-Jun, Sun, Ying, Ma, Jun, Hong, Ming-Huang, and Chen, Ming-Yuan
- Subjects
- *
LONGITUDINAL method , *METASTASIS , *MULTIVARIATE analysis , *PROBABILITY theory , *RADIOTHERAPY , *SURVIVAL , *STATISTICAL significance , *RETROSPECTIVE studies , *DISEASE progression , *DESCRIPTIVE statistics , *PROGNOSIS ,NASOPHARYNX tumors - Abstract
Background To evaluate the survival benefit of intensity-modulated radiotherapy (IMRT) compared with conventional two-dimensional radiotherapy (2D-CRT) in nasopharyngeal carcinoma (NPC) using a large cohort with long follow-up. Methods We retrospectively analysed 7081 non-metastatic NPC patients who received curative IMRT or 2D-CRT from February 2002 to December 2011. Results Of the 7081 patients, 2245 (31.7%) were administered IMRT, while 4836 (68.3%) were administered 2D-CRT. At 5 years, the patients administered IMRT had significantly higher local relapse-free survival (LRFS), loco-regional relapse-free survival (LRRFS), progression-free survival (PFS) and overall survival (OS) (95.6%, 92.5%, 82.1% and 87.4%, respectively) than those administered 2D-CRT (90.8%, 88.5%, 76.7% and 84.5%, respectively; p < 0.001). The distant metastasis-free survival (DMFS) was higher for IMRT than 2D-CRT, with borderline significance (87.6% and 85.7%, respectively; p = 0.056). However, no difference was observed between IMRT and 2D-CRT in nodal relapse-free survival (NRFS; 96.3% and 97.4%, respectively; p = 0.217). Multivariate analyses showed that IMRT was an independent protective prognostic factor for LRFS, LRRFS and PFS, but not NRFS, DMFS or OS. Conclusions IMRT provided an improved LRFS, LRRFS and PFS in both the early and advanced T classifications and overall stage for non-disseminated NPC compared with 2D-CRT. However, no significant advantage was observed in NRFS, DMFS or OS when IMRT was used. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
5. Establishment and validation of M1 stage subdivisions for de novo metastatic nasopharyngeal carcinoma to better predict prognosis and guide treatment.
- Author
-
Zou, Xiong, You, Rui, Liu, Huai, He, Yu-Xiang, Xie, Guo-Feng, Xie, Zhi-Hai, Li, Ji-Bin, Jiang, Rou, Liu, Li-Zhi, Li, Li, Zhang, Meng-Xia, Liu, You-Ping, Hua, Yi-Jun, Guo, Ling, Qian, Chao-Nan, Mai, Hai-Qiang, Chen, Dong-Ping, Luo, Ying, Shen, Liang-Fang, and Hong, Ming-Huang
- Subjects
- *
METASTASIS , *SURVIVAL , *TUMOR classification , *PROPORTIONAL hazards models , *CHEMORADIOTHERAPY , *CLASSIFICATION , *PROGNOSIS , *TUMOR treatment ,NASOPHARYNX tumors - Abstract
Background To better manage patients with de novo metastatic NPC (mNPC) including easily identifying individuals' survival outcomes and accurately choosing the most suitable treatment. Materials and methods Three independent cohorts of mNPC patients (a training set of n = 462, an internal prospective validation set of n = 272 and an external prospective validation set of n = 243) were studied. The radiological characteristics of distant metastases, including number of metastatic locations, number of metastatic lesions and size of metastatic lesions, were carefully defined based on imaging data. These three factors and other potential prognostic factors were comprehensively analysed and were further integrated into new subdivisions of stage M1 using a Cox proportional hazards model. Results We successfully subdivided the M1 stage into three categories: M1a, oligo metastasis without liver involvement; M1b, multiple metastases without liver involvement; and M1c, liver involvement irrespective of metastatic lesions. The 3-year overall survival ranged from 54.5% to 72.8%, from 34.3% to 41.6% and from 22.6.0%–23.6% for M1a, M1b and M1c, respectively ( P < 0.001). Systemic chemotherapy combined with radical loco-regional radiotherapy may benefit patients in M1a and M1b, not in M1c. Further aggressive treatment of metastatic lesions based on systemic chemotherapy and definitive loco-regional radiotherapy showed no survival benefit, even for patients in M1a ( P > 0.05). Conclusion The subdividing of M1 provided promising prognostic value and could aid clinicians in choosing the most suitable treatment for de novo mNPC patients. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
6. New surgical staging system for patients with recurrent nasopharyngeal carcinoma based on the AJCC/UICC rTNM classification system.
- Author
-
You, Rui, Zou, Xiong, Wang, Shun-Lan, Jiang, Rou, Tang, Lin-Quan, Zhang, Wei-Dong, Li, Li, Zhang, Meng-Xia, Shen, Guo-Ping, Guo, Ling, Qian, Chao-Nan, Mai, Hai-Qiang, Ma, Jun, Hong, Ming-Huang, and Chen, Ming-Yuan
- Subjects
- *
STATISTICAL sampling , *SURVIVAL , *DISEASE relapse , *PROPORTIONAL hazards models , *DESCRIPTIVE statistics , *TUMOR grading , *PROGNOSIS ,NASOPHARYNX tumors - Abstract
Background Recurrent tumour, node and metastasis (rTNM) stage system does not have an outstanding prognostic value for survival outcome of patients with recurrent nasopharyngeal carcinoma (rNPC) and it cannot aid the clinicians to choose the most suitable treatment for these patients. Methods In total, 894 rNPC patients were consecutively enroled. All recurrent (r) tumour (T) stages (rT) and node (N) stages (rN) were stratified as resectable and unresectable based on the imaging data of the head and neck. These stages were re-subdivided into surgical T stages (sT) and surgical N stages (sN) with similar clinical characteristics and death risks and were re-integrated into a new ‘surgical’ stage using a Cox proportional hazards model. Results The 5-year overall survival (OS) was 72.0%, 55.1%, 21.1% and 10.1% in ‘surgical’ stages I, II, III and IV, respectively ( P < 0.001). The ‘surgical’ stage was a significant independent prognostic factor for OS (hazard ratio [HR] 1.78, P < 0.001) and exhibited enhanced prognostic value compared with the rTNM staging system (area under receiver operating characteristics 0.68 versus 0.63, P < 0.001). Endoscopic nasopharyngectomy and intensity-modulated radiation therapy were significant independent positive prognostic factors for the OS of patients with primary lesions in ‘surgical’ stage I/II and ‘surgical’ stage III, respectively ( P < 0.05). A combination of aggressive treatments for loco-regional lesions exhibited a beneficial trend for OS of patients with ‘surgical’ stage IV ( P > 0.05). Conclusions Compared with the rTNM stage system, the ‘surgical’ staging system exhibited enhanced prognostic value for rNPC patient survival and could aid clinicians in choosing the most suitable treatment for rNPC patients. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.